Bouchey Financial Group’s Pacira BioSciences PCRX Stock Holding History

Bouchey Financial Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,500	Closed	-$220K	–	131
2023 Q2	$220K	Hold	5,500	–	–	0.03%	103
2023 Q1	$224K	Hold	5,500	–	–	0.03%	94
2022 Q4	$212K	Hold	5,500	–	–	0.03%	86
2022 Q3	$293K	Hold	5,500	–	–	0.04%	73
2022 Q2	$321K	Hold	5,500	–	–	0.05%	68
2022 Q1	$420K	Hold	5,500	–	–	0.06%	63
2021 Q4	$331K	Hold	5,500	–	–	0.04%	75
2021 Q3	$308K	Hold	5,500	–	–	0.04%	72
2021 Q2	$334K	Hold	5,500	–	–	0.05%	57
2021 Q1	$385K	Buy	5,500 +1,000	+22%	+$71.4K	0.06%	55
2020 Q4	$269K	Hold	4,500	–	–	0.05%	65
2020 Q3	$271K	Hold	4,500	–	–	0.05%	55
2020 Q2	$236K	Buy	+4,500	New	+$188K	0.05%	58
2020 Q1	–	Sell	-4,500	Closed	-$204K	–	69
2019 Q4	$204K	Buy	+4,500	New	+$191K	0.05%	78
2018 Q4	–	Sell	-4,500	Closed	-$221K	–	77
2018 Q3	$221K	Buy	+4,500	New	+$195K	0.05%	68
2018 Q1	–	Sell	-4,500	Closed	-$205K	–	69
2017 Q4	$205K	Buy	+4,500	New	+$178K	0.06%	66
2016 Q2	–	Sell	-4,550	Closed	-$241K	–	66
2016 Q1	$241K	Hold	4,550	–	–	0.1%	53
2015 Q4	$349K	Buy	+4,550	New	+$258K	0.15%	45
2015 Q3	–	Sell	-4,500	Closed	-$318K	–	64
2015 Q2	$318K	Sell	4,500 -1,700	-27%	-$134K	0.14%	48
2015 Q1	$551K	Sell	6,200 -300	-5%	-$30.4K	0.25%	41
2014 Q4	$576K	Buy	6,500 +2,000	+44%	+$189K	0.27%	41
2014 Q3	$436K	Sell	4,500 -1,500	-25%	-$146K	0.22%	46
2014 Q2	$551K	Hold	6,000	–	–	0.3%	44
2014 Q1	$420K	Hold	6,000	–	–	0.26%	47
2013 Q4	$390K	Buy	+6,000	New	+$315K	0.27%	46

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Bouchey Financial Group's PCRX Position: Q3 2023 in Review

Bouchey Financial Group sold out of Pacira BioSciences (PCRX) in Q3 2023, closing a stake of 5,500 shares — an estimated $220K sold.

Bouchey Financial Group first reported a position in PCRX in Q4 2013 and held it in 25 quarters. The position peaked at $576K in Q4 2014. 261 funds tracked by Wall St. Rank hold PCRX as of Q3 2023.

Bouchey Financial Group reported no remaining Pacira BioSciences position as of Q3 2023 after selling out during the quarter.
Bouchey Financial Group sold 5,500 Pacira BioSciences shares in Q3 2023, an estimated $220K.
Bouchey Financial Group first reported a position in Pacira BioSciences in Q4 2013 and held it in 25 quarters.
Bouchey Financial Group's Pacira BioSciences position peaked at $576K in Q4 2014.
261 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2023.

Based on Bouchey Financial Group's 13F filing for Q3 2023, filed 24 Oct 2023.